These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Comparison of the bioavailability of cyanocobalamin from capsule and liquid dosage forms. Baun DC, Bowen BM, Wood DE. Am J Hosp Pharm; 1975 Oct; 32(10):1047-9. PubMed ID: 1190217 [Abstract] [Full Text] [Related]
24. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis. Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M. J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431 [Abstract] [Full Text] [Related]
28. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. Wu Y, Loper A, Landis E, Hettrick L, Novak L, Lynn K, Chen C, Thompson K, Higgins R, Batra U, Shelukar S, Kwei G, Storey D. Int J Pharm; 2004 Nov 05; 285(1-2):135-46. PubMed ID: 15488686 [Abstract] [Full Text] [Related]
30. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers. Boonleang J, Panrat K, Tantana C, Krittathanmakul S, Jintapakorn W. Clin Ther; 2007 Apr 05; 29(4):703-10. PubMed ID: 17617293 [Abstract] [Full Text] [Related]
31. Trials of clear aceclofenac-loaded soft capsules with accelerated oral absorption in human subjects. Yong CS, Oh YK, Lee KH, Park SM, Park YJ, Gil YS, Yu CH, Yoo BK, Woo JS, Kim JO, Rhee JD, Kim CK, Choi HG. Int J Pharm; 2005 Sep 30; 302(1-2):78-83. PubMed ID: 16107306 [Abstract] [Full Text] [Related]
32. [Biological availability of different oral cimetidine preparations in the dog]. Viernstein H, Plass H, Turnheim K. Arzneimittelforschung; 1990 Jun 30; 40(6):675-8. PubMed ID: 2397003 [Abstract] [Full Text] [Related]
37. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study. Kuentz M, Nick S, Parrott N, Röthlisberger D. Eur J Pharm Sci; 2006 Jan 30; 27(1):91-9. PubMed ID: 16219449 [Abstract] [Full Text] [Related]
40. Approaches for the development of solid and semi-solid lipid-based formulations. Jannin V, Musakhanian J, Marchaud D. Adv Drug Deliv Rev; 2008 Mar 17; 60(6):734-46. PubMed ID: 18045728 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]